Top Markets
Coin of the day
BillionToOne, Inc. BillionToOne, Inc.

BillionToOne, Inc.

BLLN
Rangering i aksjer #3836
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Aksjekurs
$99.89
Sist synkronisert: 2026-08-25
Markedsverdi
$4.59B
Endring (1 dag)
3.26%
Endring (1 år)
-
Land
US
Handel BillionToOne, Inc. (BLLN)

Kategori

P/S-forhold for BillionToOne, Inc. (BLLN)
P/S-forhold per 2026 TTM: 0
Ifølge BillionToOne, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for BillionToOne, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
5.80 -
US